Mandatory Product Listing

ODSP’s Cara Welch talks FDA priorities and resources in evolved market

15-Sep-2023 By Asia Sherman

The National Institutes of Health kicked off its annual Office of Dietary Supplements Seminar Series this week with a presentation by Dr. Cara Welch on how the Food and Drug Administration (FDA) regulates the dietary supplement marketplace.

ODSP’s director on NDIs, MPL, and NMN

27-Apr-2023 By Danielle Masterson

NutraIngredients-USA caught up with Cara Welch, PhD, Director of FDA's Office of Dietary Supplement Programs. Welch talked inspections, made the case for MPL and hinted NDI guidance is on the way.

FDA commissioners calls for supplements listing, wider regulatory changes

01-Mar-2023 By Stephen Daniells

Robert Califf, MD, Commissioner of Food and Drugs, has stated his hope for an “an improved framework to appropriately regulate dietary supplements”, including product listing.

Steve Mister on proposed FDA reorg, MPL, CBD, and CRN at 50

02-Feb-2023 By Stephen Daniells

The first month of 2023 is over, and already there’s some big developments (or non-developments in the case of CBD) for the US dietary supplements industry. We caught up with Steve Mister, president and CEO of the Council for Responsible Nutrition, to...

Mandatory Product Listing not included in omnibus spending bill

22-Dec-2022 By Stephen Daniells

Attempts to include provisions establishing mandatory product listing (MPL) for dietary supplements in the FY 2023 omnibus spending bill have failed.

Guest Article: NPA Chief on 2022’s industry sagas and what these mean for 2023

20-Dec-2022 By Daniel Fabricant, PhD. President & CEO, the Natural Products Association (NPA)

As social creatures were often reluctant to pick sides. It feels personal that we’re picking one person or group of people over another. However, for our industry, the reality is that there are divisive issues.

Durbin seeks to add MPL provisions back into funding resolution

09-Dec-2022 By Hank Schultz

Senator Dick Durbin, D-IL, has called upon his colleagues to support the inclusion of Mandatory Product Listing language for dietary supplements into an omnibus funding bill that must be passed before mid December.

AHPA’s McGuffin on supply chain, MPL, climate change, and more

22-Nov-2022 By Stephen Daniells

Supply chain issues appear to be easing for the herbal supplements sector, says Michael McGuffin, president of the American Herbal Products Association, but the key lesson from the past couple of years is that supply chain management is not simple.

New Congress could provide opening for rules that could burnish industry’s reputation, CRN says

22-Nov-2022 By Hank Schultz

A shift in the relative power bases in the US House of Representatives could provide a window to make changes to dietary supplement industry regulation that could help all its players, said Steve Mister, head of the Council for Responsible Nutrition....

CRN’s Mister: The precautionary principle is making a resurgence

17-Oct-2022 By Stephen Daniells

The global dietary supplements industry must be aware of renewed use of the precautionary principle by regulators around the world, and combined with negative media creates a “constellation of factors is a recipe for concern”, CRN’s Steve Mister said...

Durbin offers amendment to restore MPL to stopgap funding bill

29-Sep-2022 By Hank Schultz

Sen. Dick Durbin, D-IL, has offered an amendment to the stopgap federal government funding measure currently before Congress that would restore a Mandatory Product Listing requirement for dietary supplements.

Stopgap funding bill lacks any provisions specific to supplement industry

27-Sep-2022 By Hank Schultz

As had been expected, the final language of the stopgap measure to fund the federal government into December has no provisions relating to the dietary supplement industry.

MPL language appears destined to be stripped from final FDA fees bill

16-Sep-2022 By Hank Schultz

Preliminary indications are that the mandatory product listing language won’t be included in the final FDA fees reauthorization bill now making its way through Congress.

Top 8 takeaways from Regulatory Summit

26-Jul-2022 By Danielle Masterson

This year’s Dietary Supplement Regulatory Summit in Washington, DC, featured updates and insights from top FDA officials, including the Office of Dietary Supplement Programs along with top stakeholders and industry experts. Here are a few key takeaways...

Sen Burr strips out supplement provisions from new FDA user fee bill

15-Jul-2022 By Stephen Daniells

Senator Richard Burr (R-NC), the ranking member of the Senate HELP Committee, has introduced a reauthorization of FDA User Fee Programs which does not include dietary supplement provisions.

AHPA urges stakeholders to oppose MPL provisions in FDA fees bill

30-Jun-2022 By Hank Schultz

The American Herbal Products Association is urging members and stakeholders to contact lawmakers to oppose the mandatory product listing language that has been attached to a ‘must pass’ fee reauthorization bill.

Dr Rob Wildman on NDI submissions, implementing MPL

28-Jun-2022 By Danielle Masterson

This year’s International Society of Sports Nutrition Annual Conference & Expo marked its 19th year promoting the science and application of evidence-based sports nutrition and supplementation. NutraIngredients-USA was there to hear about the latest...

Industry stakeholders spar over whether pushing for MPL has been tactical error

16-Jun-2022 By Hank Schultz

Mandatory Product Listing can still be a good idea for industry, proponents maintain, even if the latest legislative iteration has failed to garner support from stakeholders.

Trade organizations line up against bill that includes new supplement regulations

15-Jun-2022 By Hank Schultz

Three trade organizations joined forces in opposing the FDA Safety and Landmark Advancement Act of 2022 (FDASLA), a fee authorization bill that includes provisions aimed at tightening dietary supplement regulations.

Romney's amendments to Murray/Burr bill called ‘negotiating tactic’

14-Jun-2022 By Hank Schultz

Amendments offered by Sen. Mitt Romney, R-UT, could soften some of the hardest edges in an FDA fee reauthorization bill that includes language meant to tighten the regulation of dietary supplements. But the bill still sets a very troubling precedent,...

Guest article

Mandatory Product Listing: It Won’t “Wash the Windows” Either!

29-Apr-2022 By Steve Mister, CRN President and CEO

This week, Senators Durbin (D-IL) and Braun (R-IN) introduced S. 4090, the Dietary Supplement Listing Act of 2022, on a bipartisan basis. The legislation would create a mandatory product listing for dietary supplements, similar to the voluntary Supplement...

FDA proposes mandatory product listing, industry stakeholders divided

29-Mar-2022 By Danielle Masterson

The fiscal year 2023 budget request marks a 34% increase and highlights immediate priorities, including modernizing DSHEA.

CRN’s Mister on NAC: ‘This isn’t a one ingredient issue’

14-Mar-2022 By Stephen Daniells

As the uncertainty around the regulatory status of NAC (N-acetyl cysteine) continues, it is important the industry doesn’t lose this for the precedent it sets for other potential ingredients, said CRN’s Steve Mister.

UNPA’s Israelsen on proposed mandatory product listing, supply chain issues, and China

16-Nov-2021 By Stephen Daniells

Draft bills circulating around Congress to codify mandatory product listings for dietary supplements are progressing, but many remain cautious and concerned about the proposals. “The details are what matter here,” says Loren Israelsen, president of the...

CRN on mandatory product listing: ‘We’re making some real progress on the negotiations’

02-Nov-2021 By Stephen Daniells

Draft bills circulating around Congress to codify mandatory product listings for dietary supplements are progressing, and could be introduced soon, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).

AHPA member survey shows more opposition than support for mandatory product listing

07-Oct-2021 By Stephen Daniells

A recent survey by the American Herbal Products Association showed that over 50% of its members oppose a mandatory product listing for dietary supplements, with only 18% supporting the listing.